Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg
|
January 1, 1995
[Tendinopathies and fluoroquinolones: a public health problem? Value of drug monitoring studies]
C Pierfitte
Therapie
|
July 1, 1996
Tendon disorders with fluoroquinolones
C Pierfitte, R J Royer
The New England Journal of Medicine
|
January 19, 1995
More on fluoroquinolone antibiotics and tendon rupture
C Pierfitte, P Gillet, R J Royer
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg
|
January 1, 1996
[Pharmacologic monitoring in elderly persons]
R J Royer, C Pierfitte, B Hanesse
Therapie
|
March 1, 1995
[Opinion survey of European pharmacovigilance: opinion of French practitioners]
C Pierfitte, B Hanesse, R J Royer
Therapie
|
January 1, 1994
Features of tendon disorders with fluoroquinolones
R J Royer, C Pierfitte, P Netter
British Journal of Clinical Pharmacology
|
June 10, 2000
The link between sunshine and phototoxicity of sparfloxacin
C Pierfitte, R J Royer, N Moore, et al.
British Journal of Clinical Pharmacology
|
April 24, 1999
Is reporting rate a good predictor of risks associated with drugs?
C Pierfitte, B Bégaud, R Lagnaoui, et al.
Clinical Pharmacology and Therapeutics
|
June 15, 2001
Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects
N Moore, C Pierfitte, F Pehourcq, et al.
Therapie
|
September 1, 1994
[Pseudomembranous colitis associated with josamycin]
M Maignan, H Schuhmacher, C Pierfitte, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg
|
January 1, 1995
[Tendinopathies and fluoroquinolones: a public health problem? Value of drug monitoring studies]
C Pierfitte
Therapie
|
July 1, 1996
Tendon disorders with fluoroquinolones
C Pierfitte, R J Royer
The New England Journal of Medicine
|
January 19, 1995
More on fluoroquinolone antibiotics and tendon rupture
C Pierfitte, P Gillet, R J Royer
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg
|
January 1, 1996
[Pharmacologic monitoring in elderly persons]
R J Royer, C Pierfitte, B Hanesse
Therapie
|
March 1, 1995
[Opinion survey of European pharmacovigilance: opinion of French practitioners]
C Pierfitte, B Hanesse, R J Royer
Therapie
|
January 1, 1994
Features of tendon disorders with fluoroquinolones
R J Royer, C Pierfitte, P Netter
British Journal of Clinical Pharmacology
|
June 10, 2000
The link between sunshine and phototoxicity of sparfloxacin
C Pierfitte, R J Royer, N Moore, et al.
British Journal of Clinical Pharmacology
|
April 24, 1999
Is reporting rate a good predictor of risks associated with drugs?
C Pierfitte, B Bégaud, R Lagnaoui, et al.
Clinical Pharmacology and Therapeutics
|
June 15, 2001
Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects
N Moore, C Pierfitte, F Pehourcq, et al.
Therapie
|
September 1, 1994
[Pseudomembranous colitis associated with josamycin]
M Maignan, H Schuhmacher, C Pierfitte, et al.
Page
of 2